Similar articles for PMID: 19376978

Year	Number of Results
1993	1
1996	1
1997	2
1998	1
1999	2
2000	5
2001	6
2002	7
2003	1
2005	3
2006	2
2007	7
2008	9
2009	7
2010	2
2011	2
2012	5
2013	1
2014	4
2015	3
2016	1
2017	8
2018	6
2019	5
2020	6
2021	2
2022	1
2024	0

1

Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36.

Silverstein RL. Silverstein RL. Cleve Clin J Med. 2009 Apr;76 Suppl 2(Suppl 2):S27-30. doi: 10.3949/ccjm.76.s2.06. Cleve Clin J Med. 2009. PMID: 19376978 Free PMC article. Review.

2

Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis.

Silverstein RL, Li W, Park YM, Rahaman SO. Silverstein RL, et al. Trans Am Clin Climatol Assoc. 2010;121:206-20. Trans Am Clin Climatol Assoc. 2010. PMID: 20697562 Free PMC article. Review.

3

Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation.

Hsu YW, Hsu FF, Chiang MT, Tsai DL, Li FA, Angata T, Crocker PR, Chau LY. Hsu YW, et al. J Biomed Sci. 2021 Jan 5;28(1):5. doi: 10.1186/s12929-020-00698-z. J Biomed Sci. 2021. PMID: 33397354 Free PMC article.

4

A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.

Chen K, Febbraio M, Li W, Silverstein RL. Chen K, et al. Circ Res. 2008 Jun 20;102(12):1512-9. doi: 10.1161/CIRCRESAHA.108.172064. Epub 2008 May 22. Circ Res. 2008. PMID: 18497330 Free PMC article.

5

Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients.

Yamashita S, Hirano K, Kuwasako T, Janabi M, Toyama Y, Ishigami M, Sakai N. Yamashita S, et al. Mol Cell Biochem. 2007 May;299(1-2):19-22. doi: 10.1007/s11010-005-9031-4. Mol Cell Biochem. 2007. PMID: 16670819

6

The role of CD36 receptor in the pathogenesis of atherosclerosis.

Choromańska B, Myśliwiec P, Choromańska K, Dadan J, Chabowski A. Choromańska B, et al. Adv Clin Exp Med. 2017 Jul;26(4):717-722. doi: 10.17219/acem/62325. Adv Clin Exp Med. 2017. PMID: 28691408 Free article. Review.

7

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL. Podrez EA, et al. J Biol Chem. 2002 Oct 11;277(41):38517-23. doi: 10.1074/jbc.M205924200. Epub 2002 Jul 26. J Biol Chem. 2002. PMID: 12145296 Free article.

8

Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.

Silverstein RL. Silverstein RL. Clin Lipidol. 2009 Dec;4(6):767. doi: 10.2217/clp.09.57. Clin Lipidol. 2009. PMID: 20161667 Free PMC article.

9

Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis.

Nicholson AC, Han J, Febbraio M, Silversterin RL, Hajjar DP. Nicholson AC, et al. Ann N Y Acad Sci. 2001 Dec;947:224-8. doi: 10.1111/j.1749-6632.2001.tb03944.x. Ann N Y Acad Sci. 2001. PMID: 11795270 Review.

10

Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36.

Zhu W, Li W, Silverstein RL. Zhu W, et al. Blood. 2012 Jun 21;119(25):6136-44. doi: 10.1182/blood-2011-10-387506. Epub 2012 Mar 19. Blood. 2012. PMID: 22431576 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year